Citigroup
USNA icon

Citigroup’s Usana Health Sciences USNA Stock Holding History

Citigroup’s Portfolio USNA Stock Details USNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$26.4K Buy
1,513
+118
+8% +$2.34K ﹤0.01% 4748
2025
Q4 		$27.4K Sell
1,395
-4,206
-75% -$87.3K ﹤0.01% 4785
2025
Q3 		$154K Sell
5,601
-8,779
-61% -$270K ﹤0.01% 4098
2025
Q2 		$439K Sell
14,380
-3,670
-20% -$104K ﹤0.01% 3706
2025
Q1 		$487K Buy
18,050
+216
+1% +$6.84K ﹤0.01% 3699
2024
Q4 		$640K Buy
17,834
+3,473
+24% +$130K ﹤0.01% 3656
2024
Q3 		$545K Buy
14,361
+6,373
+80% +$262K ﹤0.01% 3677
2024
Q2 		$361K Buy
7,988
+863
+12% +$39.7K ﹤0.01% 3589
2024
Q1 		$346K Sell
7,125
-2,611
-27% -$128K ﹤0.01% 3765
2023
Q4 		$522K Buy
9,736
+2,482
+34% +$126K ﹤0.01% 3383
2023
Q3 		$425K Sell
7,254
-4,356
-38% -$272K ﹤0.01% 3181
2023
Q2 		$732K Buy
11,610
+1,841
+19% +$117K ﹤0.01% 3077
2023
Q1 		$614K Buy
9,769
+550
+6% +$32.8K ﹤0.01% 2966
2022
Q4 		$490K Buy
9,219
+2,194
+31% +$119K ﹤0.01% 3191
2022
Q3 		$394K Buy
7,025
+397
+6% +$26.2K ﹤0.01% 3405
2022
Q2 		$479K Sell
6,628
-4,960
-43% -$369K ﹤0.01% 3264
2022
Q1 		$921K Sell
11,588
-10
-0.1% -$902 ﹤0.01% 3051
2021
Q4 		$1.17M Buy
11,598
+2,378
+26% +$237K ﹤0.01% 3088
2021
Q3 		$850K Sell
9,220
-2,184
-19% -$210K ﹤0.01% 3210
2021
Q2 		$1.17M Sell
11,404
-8,365
-42% -$840K ﹤0.01% 3100
2021
Q1 		$1.93M Buy
19,769
+12,366
+167% +$1.13M ﹤0.01% 2519
2020
Q4 		$571K Buy
7,403
+2,234
+43% +$173K ﹤0.01% 4081
2020
Q3 		$381K Sell
5,169
-4,515
-47% -$362K ﹤0.01% 4087
2020
Q2 		$711K Buy
9,684
+1,651
+21% +$130K ﹤0.01% 3910
2020
Q1 		$464K Sell
8,033
-1,995
-20% -$139K ﹤0.01% 3929
2019
Q4 		$788K Sell
10,028
-4,928
-33% -$363K ﹤0.01% 4005
2019
Q3 		$1.02M Sell
14,956
-22,318
-60% -$1.5M ﹤0.01% 3625
2019
Q2 		$2.96M Buy
37,274
+7,003
+23% +$555K ﹤0.01% 2415
2019
Q1 		$2.54M Buy
30,271
+5,047
+20% +$527K ﹤0.01% 2429
2018
Q4 		$2.97M Sell
25,224
-5,786
-19% -$669K ﹤0.01% 2304
2018
Q3 		$3.74M Buy
31,010
+20,712
+201% +$2.57M ﹤0.01% 2148
2018
Q2 		$1.19M Buy
10,298
+4,995
+94% +$546K ﹤0.01% 3174
2018
Q1 		$456K Sell
5,303
-1,964
-27% -$152K ﹤0.01% 4082
2017
Q4 		$538K Buy
7,267
+1,657
+30% +$111K ﹤0.01% 4025
2017
Q3 		$324K Buy
5,610
+1,981
+55% +$117K ﹤0.01% 4556
2017
Q2 		$233K Sell
3,629
-8,038
-69% -$495K ﹤0.01% 4665
2017
Q1 		$672K Sell
11,667
-6,411
-35% -$383K ﹤0.01% 3619
2016
Q4 		$1.11M Buy
18,078
+15,182
+524% +$989K ﹤0.01% 3574
2016
Q3 		$200K Sell
2,896
-1,278
-31% -$84.3K ﹤0.01% 4652
2016
Q2 		$233K Sell
4,174
-7,970
-66% -$481K ﹤0.01% 4352
2016
Q1 		$737K Buy
12,144
+6,740
+125% +$397K ﹤0.01% 3698
2015
Q4 		$346K Buy
5,404
+3,422
+173% +$222K ﹤0.01% 4241
2015
Q3 		$133K Sell
1,982
-2,510
-56% -$178K ﹤0.01% 4794
2015
Q2 		$307K Sell
4,492
-196
-4% -$12.4K ﹤0.01% 4114
2015
Q1 		$261K Buy
4,688
+40
+0.9% +$2.05K ﹤0.01% 4285
2014
Q4 		$238K Buy
4,648
+1,004
+28% +$49.3K ﹤0.01% 4538
2014
Q3 		$134K Buy
3,644
+1,154
+46% +$41.6K ﹤0.01% 4520
2014
Q2 		$97K Buy
2,490
+140
+6% +$5.2K ﹤0.01% 4690
2014
Q1 		$89K Sell
2,350
-4,858
-67% -$170K ﹤0.01% 5098
2013
Q4 		$273K Buy
7,208
+3,334
+86% +$128K ﹤0.01% 4381
2013
Q3 		$168K Sell
3,874
-6,228
-62% -$250K ﹤0.01% 4312
2013
Q2 		$366K Buy
+10,102
New +$307K ﹤0.01% 3753

Other funds holding USNA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Pzena Investment Management
Pzena Investment Management New York $30.8B AUM 11.29% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Citigroup's USNA Position: Q1 2026 in Review

Citigroup increased its Usana Health Sciences (USNA) stake by 8.5% in Q1 2026, buying an estimated $2.34K and bringing the position to 1,513 shares worth $26.4K. The position accounts for ﹤0.01% of the portfolio, ranked #4748.

Citigroup first reported a position in USNA in Q2 2013 and has held it in 52 quarters since. The position peaked at $3.74M in Q3 2018. 139 funds tracked by Wall St. Rank hold USNA as of Q1 2026.

  • Citigroup held 1,513 shares of Usana Health Sciences worth $26.4K as of Q1 2026.
  • Citigroup bought 118 Usana Health Sciences shares in Q1 2026, an estimated $2.34K.
  • Usana Health Sciences made up ﹤0.01% of Citigroup's portfolio in Q1 2026, its #4748 holding.
  • Citigroup first reported a position in Usana Health Sciences in Q2 2013 and has held it in 52 quarters since.
  • Citigroup's Usana Health Sciences position peaked at $3.74M in Q3 2018.
  • 139 funds tracked by Wall St. Rank held Usana Health Sciences as of Q1 2026.

Based on Citigroup's 13F filing for Q1 2026, filed 11 May 2026.